Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleDiscussions with Leaders

Advancing Clinical Trial Innovation in Pancreatic Cancer

A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin

Diane M. Simeone, Ken Herrmann and Johannes Czernin
Journal of Nuclear Medicine February 2023, 64 (2) 185-187; DOI: https://doi.org/10.2967/jnumed.123.265432
Diane M. Simeone
1New York University Langone, New York, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
2Universitätsklinikum Essen, Essen, Germany and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
3David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 2 185-187
DOI 
https://doi.org/10.2967/jnumed.123.265432
PubMed 
36725247

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online February 1, 2023.

Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2023 to April 2025

AbstractFullPdf
Feb 2023048760
Mar 2023043535
Apr 2023041519
May 2023020214
Jun 2023021112
Jul 2023025015
Aug 202303189
Sep 2023026314
Oct 2023010412
Nov 202301378
Dec 202304617
Jan 2024017315
Feb 202401555
Mar 2024010921
Apr 202404412
May 202402410
Jun 20240396
Jul 202409622
Aug 202409226
Sep 20240227
Oct 202401012
Nov 202401512
Dec 20240107
Jan 202502118
Feb 202502710
Mar 20250107
Apr 202503112
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (2)
Journal of Nuclear Medicine
Vol. 64, Issue 2
February 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advancing Clinical Trial Innovation in Pancreatic Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Advancing Clinical Trial Innovation in Pancreatic Cancer
Diane M. Simeone, Ken Herrmann, Johannes Czernin
Journal of Nuclear Medicine Feb 2023, 64 (2) 185-187; DOI: 10.2967/jnumed.123.265432

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advancing Clinical Trial Innovation in Pancreatic Cancer
Diane M. Simeone, Ken Herrmann, Johannes Czernin
Journal of Nuclear Medicine Feb 2023, 64 (2) 185-187; DOI: 10.2967/jnumed.123.265432
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Stakeholders of Theranostics
  • New Approaches in Radiopharmaceutical Development
  • Advancing Tomorrow’s Cancer Medicines
Show more Discussions with Leaders

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire